dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Yoshino, T. |
dc.contributor.author | Cleary, J. M. |
dc.contributor.author | Van Cutsem, Eric |
dc.contributor.author | Mayer, Robert |
dc.contributor.author | Ohtsu, Atsushi |
dc.contributor.author | Shinozaki, E. |
dc.contributor.author | Argilés Martinez, Guillem |
dc.date.accessioned | 2021-10-19T10:19:26Z |
dc.date.available | 2021-10-19T10:19:26Z |
dc.date.issued | 2020-01 |
dc.identifier.citation | Yoshino T, Cleary JM, Van Cutsem E, Mayer RJ, Ohtsu A, Shinozaki E, et al. Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials. Ann Oncol. 2020 Jan;31(1):88–95. |
dc.identifier.issn | 0923-7534 |
dc.identifier.uri | https://hdl.handle.net/11351/6407 |
dc.description | Neutropènia induïda per quimioteràpia; Càncer colorectal metastàtic |
dc.description.sponsorship | This study was supported by Taiho Pharmaceutical Co., Ltd., Tokyo, Japan and Taiho Oncology, Inc., Princeton, NJ, USA. No grant numbers are applicable. |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation.ispartofseries | Annals of Oncology;31(1) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Recte - Càncer - Quimioteràpia |
dc.subject | Còlon - Càncer - Quimioteràpia |
dc.subject | Neutropènia |
dc.subject.mesh | Colorectal Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | Neutropenia |
dc.title | Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1016/j.annonc.2019.10.005 |
dc.subject.decs | neoplasias colorrectales |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | neutropenia |
dc.relation.publishversion | https://doi.org/10.1016/j.annonc.2019.10.005 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Yoshino T, Ohtsu A] Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan. [Cleary JM, Mayer RJ] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. [Van Cutsem E] Division of Digestive Oncology, University Hospitals Leuven and KU Leuven, Leuven, Belgium. [Shinozaki E] Department of Gastroenterology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. [Argilés G] Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 31912801 |
dc.identifier.wos | 000516712000014 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |